These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22898135)

  • 21. Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
    Phompradit P; Muhamad P; Wisedpanichkij R; Chaijaroenkul W; Na-Bangchang K
    Malar J; 2014 Jan; 13():23. PubMed ID: 24423390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain, Madhya Pradesh, India.
    Pathak A; Mårtensson A; Gawariker S; Mandliya J; Sharma A; Diwan V; Ursing J
    Malar J; 2014 May; 13():182. PubMed ID: 24885535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.
    Foumane Ngane V; Allico Djaman J; Culeux C; Piette N; Carnevale P; Besnard P; Fortes F; Basco LK; Tahar R
    Malar J; 2015 Mar; 14():113. PubMed ID: 25889865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
    Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
    Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.
    Ould Ahmedou Salem MS; Mint Lekweiry K; Bouchiba H; Pascual A; Pradines B; Ould Mohamed Salem Boukhary A; Briolant S; Basco LK; Bogreau H
    Malar J; 2017 Apr; 16(1):140. PubMed ID: 28381273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
    Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
    Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
    Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C
    Malar J; 2009 Jan; 8():10. PubMed ID: 19138388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
    Phompradit P; Muhamad P; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2014 Nov; 139():77-83. PubMed ID: 25004442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
    Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artemisinin resistance in Plasmodium falciparum malaria.
    Dondorp AM; Nosten F; Yi P; Das D; Phyo AP; Tarning J; Lwin KM; Ariey F; Hanpithakpong W; Lee SJ; Ringwald P; Silamut K; Imwong M; Chotivanich K; Lim P; Herdman T; An SS; Yeung S; Singhasivanon P; Day NP; Lindegardh N; Socheat D; White NJ
    N Engl J Med; 2009 Jul; 361(5):455-67. PubMed ID: 19641202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
    Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W
    Malar J; 2010 Oct; 9():273. PubMed ID: 20929590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
    Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
    Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.
    Phyo AP; Ashley EA; Anderson TJC; Bozdech Z; Carrara VI; Sriprawat K; Nair S; White MM; Dziekan J; Ling C; Proux S; Konghahong K; Jeeyapant A; Woodrow CJ; Imwong M; McGready R; Lwin KM; Day NPJ; White NJ; Nosten F
    Clin Infect Dis; 2016 Sep; 63(6):784-791. PubMed ID: 27313266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.
    Srimuang K; Miotto O; Lim P; Fairhurst RM; Kwiatkowski DP; Woodrow CJ; Imwong M;
    Malar J; 2016 Nov; 15(1):541. PubMed ID: 27825353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies.
    Brown T; Smith LS; Oo EK; Shawng K; Lee TJ; Sullivan D; Beyrer C; Richards AK
    Malar J; 2012 Sep; 11():333. PubMed ID: 22992214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
    Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
    Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.